Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoliu formula (also known as Xiao-liu formula) is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Shenzhen Traditional Chinese Medicine Hospital. It is specifically formulated for the management of endometriosis and associated chronic pelvic pain. In the framework of TCM, the formula is designed to resolve blood stasis and soften hardness, addressing the underlying pathology of endometriotic lesions. The formula is typically administered as an oral decoction or granule and is currently being evaluated in clinical trials to assess its efficacy in reducing pain scores and improving the quality of life in patients with endometriosis, potentially offering a non-hormonal alternative to standard therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoliu formula (Shenzhen Traditional Chinese Medicine Hospital).